Mayne Pharma Group Limited announced that Chief Financial Officer and Company Secretary, Nick Freeman, has tendered his resignation for family reasons to pursue another opportunity. The company has appointed Peter Paltoglou as interim CFO until a new CFO has been named. Nick will remain with Mayne Pharma until mid-June 2020 and will work with Peter to facilitate an orderly transition. Peter has been with Mayne Pharma since August 2015 most recently as Chief Development Officer with responsibility for M&A, portfolio, strategic planning, business development and licensing activities, and third-party partnerships. Peter has more than 20 years of experience in capital markets, corporate strategy and M&A. He was previously Managing Director of Investor Banking at Credit Suisse Emerging Companies in Australia. Laura Loftus has been appointed as Company Secretary, with effect from 26 March 2020. Laura
has been with Mayne Pharma since May 2014 and is an experienced company lawyer with more
than ten years of experience and wil be based in Australia.